A Pharmacokinetic Study of Single Doses of Sativex in Treatment-induced Mucositis

NCT01975688 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

10

Enrollment

INDUSTRY

Sponsor class

Stopped Slow recruitment

Conditions

Head and Neck Squamous Cell Carcinoma

Interventions

DRUG: Sativex

Sponsor

GW Pharmaceuticals Ltd